ALBT Stock Overview
Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States and China.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Avalon GloboCare Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.80 |
| 52 Week High | US$7.49 |
| 52 Week Low | US$0.78 |
| Beta | 0.51 |
| 1 Month Change | -19.75% |
| 3 Month Change | -44.66% |
| 1 Year Change | -86.49% |
| 3 Year Change | -93.20% |
| 5 Year Change | -96.87% |
| Change since IPO | -88.54% |
Recent News & Updates
Recent updates
We Think Avalon GloboCare (NASDAQ:AVCO) Has A Fair Chunk Of Debt
Sep 29
Would Avalon GloboCare (NASDAQ:AVCO) Be Better Off With Less Debt?
Jun 01Does Avalon GloboCare (NASDAQ:AVCO) Have A Healthy Balance Sheet?
Feb 23Here's Why Avalon GloboCare (NASDAQ:AVCO) Can Afford Some Debt
Oct 14Avalon Globocare to acquire SenlangBio in all-stock deal
Jun 14Is Avalon GloboCare (NASDAQ:AVCO) A Risky Investment?
May 15A Look At Avalon GloboCare's (NASDAQ:AVCO) Share Price Returns
Feb 25Have Insiders Been Buying Avalon GloboCare Corp. (NASDAQ:AVCO) Shares This Year?
Jan 30Is Avalon GloboCare (NASDAQ:AVCO) Using Too Much Debt?
Jan 04What Percentage Of Avalon GloboCare Corp. (NASDAQ:AVCO) Shares Do Insiders Own?
Nov 30Shareholder Returns
| ALBT | US Real Estate | US Market | |
|---|---|---|---|
| 7D | -16.2% | -1.7% | -0.4% |
| 1Y | -86.5% | 7.5% | 17.5% |
Return vs Industry: ALBT underperformed the US Real Estate industry which returned 7.5% over the past year.
Return vs Market: ALBT underperformed the US Market which returned 17.5% over the past year.
Price Volatility
| ALBT volatility | |
|---|---|
| ALBT Average Weekly Movement | 13.5% |
| Real Estate Industry Average Movement | 6.1% |
| Market Average Movement | 5.5% |
| 10% most volatile stocks in US Market | 14.1% |
| 10% least volatile stocks in US Market | 2.5% |
Stable Share Price: ALBT is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 14% a week.
Volatility Over Time: ALBT's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2016 | 6 | David Jin | https://www.avalon-globocare.com |
Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States and China. The company develops and delivers transformative cellular therapeutics, precision diagnostics, and clinical laboratory services. Its leading candidates are AVA-001, an anti-CD19 CAR-T, which has completed first-in-human clinical trial for relapsed/refractory (R/R) B-cell lymphoblastic leukemia; and AVA-011 that has completed pre-clinical laboratory studies and undergoing IND-enabling process development stage to generate cGMP-grade AVA-011 CAR-T cells.
Avalon GloboCare Corp. Fundamentals Summary
| ALBT fundamental statistics | |
|---|---|
| Market Cap | US$8.73m |
| Earnings (TTM) | -US$13.16m |
| Revenue (TTM) | US$1.07m |
8.1x
P/S Ratio-0.7x
P/E RatioIs ALBT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ALBT income statement (TTM) | |
|---|---|
| Revenue | US$1.07m |
| Cost of Revenue | US$993.14k |
| Gross Profit | US$78.75k |
| Other Expenses | US$13.24m |
| Earnings | -US$13.16m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.21 |
| Gross Margin | 7.35% |
| Net Profit Margin | -1,227.66% |
| Debt/Equity Ratio | 40.8% |
How did ALBT perform over the long term?
See historical performance and comparison